SCHEMBL17878730

SCHEMBL17878730

CC(C)(C)OC(=O)N1CC(C(=N)Nc2cccc([N+](=O)[O-])c2)=C(N)C1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
SIRT2 Q8IXJ6 1/20 0.44
KMT2A Q03164 9/20 0.43
MEN1 O00255 8/20 0.43
MAPT P10636 5/20 0.43
HTT P42858 4/20 0.43
ALDH1A1 P00352 4/20 0.43
POLB P06746 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
DDX3X O00571 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
NR3C2 P08235 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17877915 0.89 MEN1 (0.46) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL17878748 0.86 MAPT (0.43) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL17878874 0.83 MEN1 (0.44) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL17878694 0.78 MAPT (0.41) SMN1; SMN2KMT2AMEN1MAPTALDH1A1
SCHEMBL17878865 0.75 NR1H2 (0.38) SMN1; SMN2ALDH1A1LMNANPSR1
SCHEMBL15273052 0.73 KMT2A (0.58) SMN1; SMN2KMT2AMEN1MAPTHTT
SCHEMBL32660723 0.72 KMT2A (0.64) SMN1; SMN2KMT2AMEN1MAPTHTT
SCHEMBL31135773 0.72 SMN1; SMN2 (0.64) SMN1; SMN2SIRT2KMT2AMEN1MAPT
SCHEMBL3222110 0.72 SMN1; SMN2 (0.64) SMN1; SMN2SIRT2KMT2AMEN1MAPT
SCHEMBL14546312 0.72 NR1H2 (0.33) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016105528-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 WO disclosed